IHF — iShares U.S. Healthcare Providers ETF
Healthcare Ranked #297 of 458 tracked ETFs · Issued by iShares
IHF Price Performance — Growth of $10,000
Value of a $10,000 investment in IHF over time, compared with SPY. Both lines are rebased to $10,000 on the first shared date. Based on total returns — prices are adjusted for dividends and splits, so this assumes distributions were reinvested. Hover or tap the chart for exact values.
IHF Drawdown
The "underwater" chart: IHF's decline from its highest prior value at each point in time. It shows how deep past losses ran and how long the fund took to recover to break-even.
What If You'd Invested in IHF?
See what a lump sum in IHF would have grown to, with the option to add a regular monthly contribution on top. Figures use total returns — dividends are assumed reinvested.
Past performance doesn't predict future results. Assumes contributions on the first trading day of each month, no trading costs or taxes, and reinvested distributions. History is limited to the range published in the site's daily return data.
Overview
The iShares U.S. Healthcare Providers ETF is an iShares-managed fund tracking the healthcare sector, currently holding $1.36 billion in assets. It carries an ETFValuer grade of C with a score of 55.9 out of 100, placing it 10th out of 11 peers in its category and 297th of 458 tracked ETFs overall. The fund charges an expense ratio of 0.37%, which is slightly above the category median of 0.36%. Its dividend yield stands at 0.90%, trailing the category median of 0.98%. Concentration is notable, with the top 10 holdings accounting for 72.1% of assets and UnitedHealth Group representing 21.9% of the portfolio.
The fund was upgraded from a D to a C grade on 2026-10-14, reflecting a shift in its rating profile. Price history is available for only 3.0 years, limiting the depth of historical context. The share price of $60.38 sits at 97.1% of its 52-week range, indicating it is near the top of its recent trading band. Short-term momentum is evident, with one-month returns of +9.84% and three-month gains of +6.70%. However, the one-year return of +19.55% lags behind the category median of +24.88%, suggesting underperformance over that specific horizon despite strong year-to-date gains of +25.60%.
With a beta of 0.88, the ETF has historically moved 88% as much as the broader market. Annualized volatility is recorded at 20.11%, which is classified as moderate. The Sharpe ratio of 0.72 indicates the risk-adjusted return profile relative to its volatility. Maximum drawdowns have reached -29.85%, highlighting the potential for significant peak-to-trough declines. Liquidity is supported by an average daily volume of 640,979 shares, providing adequate trading activity for the fund.
AI-generated summary based on the data on this page.
IHF Top Holdings
| # | Holding | % of Net Assets | Value |
|---|---|---|---|
| 1 | UNITEDHEALTH GROUP INCORPORATED | 21.91% | $258M |
| 2 | CVS HEALTH CORPORATION | 14.79% | $174M |
| 3 | ELEVANCE HEALTH, INC. | 7.13% | $84M |
| 4 | HUMANA INC. | 4.68% | $55M |
| 5 | HCA HEALTHCARE, INC. | 4.49% | $53M |
| 6 | CENTENE CORPORATION | 4.22% | $50M |
| 7 | THE CIGNA GROUP | 4.00% | $47M |
| 8 | VEEVA SYSTEMS INC. | 3.98% | $47M |
| 9 | QUEST DIAGNOSTICS INCORPORATED | 3.51% | $41M |
| 10 | LABCORP HOLDINGS INC. | 3.43% | $40M |
Holdings as of 2026-06-30 per the fund's most recent SEC N-PORT-P filing. Top 10 holdings make up 72.1% of net assets — a rough gauge of concentration risk (the higher this figure, the more the fund's return depends on a handful of names). To see how IHF's holdings overlap with other ETFs you own or are considering, check the Stock Overlap tool.
Which Funds Overlap With IHF
Holding two funds that own the same companies adds cost and complexity without adding much diversification. These tracked ETFs share the most names with IHF's top 10 — VFVA overlaps most, holding 3 of the same companies as IHF's top 10 (25.9% of IHF's assets).
| ETF | Name | Shared Companies | IHF Weight | Examples |
|---|---|---|---|---|
| VFVA | Vanguard U.S. Value Factor ETF Shares | 3 | 25.9% | CVS HEALTH CORPORATION, ELEVANCE HEALTH, INC., THE CIGNA GROUP |
| RPV | Invesco S&P 500 Pure Value ETF | 3 | 23.7% | CVS HEALTH CORPORATION, HUMANA INC., CENTENE CORPORATION |
| VTV | Vanguard Morningstar Value ETF | 1 | 21.9% | UNITEDHEALTH GROUP INCORPORATED |
| SCHD | Schwab U.S. Dividend Equity ETF | 1 | 21.9% | UNITEDHEALTH GROUP INCORPORATED |
| VYM | Vanguard High Dividend Yield Index Fund ETF Shares | 1 | 21.9% | UNITEDHEALTH GROUP INCORPORATED |
Compares the top 10 reported holdings of each fund, so it's a floor on true overlap — two S&P 500 trackers overlap ~100% even when only 10 names are listed. Use the Stock Overlap tool to search by individual company.
Market Backdrop
10-Year Treasury Yield: 4.96% (as of 2026-10-22) — The yield on 10-year US Treasury bonds — the standard "risk-free rate" benchmark used to contextualize this fund’s Sharpe ratio and returns.
CBOE Volatility Index (VIX): 19.03 (as of 2026-10-22) — A real-time gauge of expected S&P 500 volatility over the next 30 days — useful context for this fund’s own volatility label.
Federal Funds Rate: 3.75% (as of 2026-09-01) — The Federal Reserve’s target policy rate, which anchors short-term borrowing costs across the economy.
What IHF's Fees Cost You
IHF charges an expense ratio of 0.37% a year, deducted automatically from the fund's value. Small percentages compound into real money — adjust the figures below to see the impact on your own numbers.
Assumes a constant gross return and no additional contributions — a simplification, but it isolates exactly what the expense ratio costs. Try the full fee calculator to model contributions and compare any two funds.
IHF Dividend Income Estimator
IHF currently yields 0.90%. Enter an amount to see the income that implies, or set a monthly income target to see the investment it would take.
Based on the fund's current trailing yield, which varies with price and distributions — treat it as an estimate, not a guarantee. Yields are not adjusted for tax.
IHF Liquidity, Domicile & Tax Treatment
Liquidity: Average daily volume is 641K/day. Higher volume and a larger fund generally mean lower round-trip trading costs. AUM of $1.36B provides ample scale, supporting tight spreads and issuer commitment to keep the fund open.
Domicile & tax treatment: IHF is a US-domiciled, SEC-registered ('40 Act) exchange-traded fund. Dividends and capital gains distributions are reported to US investors on Form 1099-DIV, and the fund is not subject to the PFIC reporting or UCITS-specific rules that apply to Irish- or Luxembourg-domiciled funds. Non-US investors should note that US-domiciled ETFs are generally subject to 30% US withholding tax on dividends (unless reduced by treaty) and to US estate tax exposure on the position — Irish-domiciled UCITS ETFs tracking the same index often avoid both, which is why non-US residents frequently prefer the UCITS equivalent where one exists. This is general information, not tax advice — consult a tax professional for your situation.
IHF Performance History
| Period | Return |
|---|---|
| 1-Day | -0.85% |
| 1-Week | +2.95% |
| 1-Month | +9.84% |
| 3-Month | +6.70% |
| 6-Month | +29.88% |
| YTD | +25.60% |
| 1-Year | +19.55% |
| 3-Year | +26.82% |
How IHF Compares to Other Healthcare ETFs
| Rank | Grade | Ticker | Name | 1-Year | Exp. Ratio | AUM |
|---|---|---|---|---|---|---|
| #31 | B+ |
XLV | State Street Health Care Select Sector SPDR ETF | +24.88% | 0.08% | $43.4B |
| #36 | B+ |
VHT | Vanguard Health Care Index Fund ETF Shares | +24.24% | 0.09% | $21.8B |
| #64 | B |
FHLC | Fidelity MSCI Health Care Index ETF | +24.43% | 0.084% | $3.54B |
| #100 | B |
IBB | iShares Biotechnology ETF | +35.23% | 0.44% | $11.2B |
| #106 | B |
XBI | State Street SPDR S&P Biotech ETF | +39.94% | 0.35% | $10.4B |
| #125 | B |
IYH | iShares U.S. Healthcare ETF | +24.20% | 0.37% | $3.96B |
| #140 | B |
PPH | VanEck Pharmaceutical ETF | +27.00% | 0.36% | $1.02B |
| #175 | B |
XPH | State Street SPDR S&P Pharmaceuticals ETF | +29.81% | 0.35% | $524M |
| #209 | C |
ARKG | ARK Genomic Revolution ETF | +57.54% | 0.75% | $2.22B |
| #297 | C |
IHF | iShares U.S. Healthcare Providers ETF | +19.55% | 0.37% | $1.36B |
| #424 | D |
IHI | iShares U.S. Medical Devices ETF | -11.17% | 0.37% | $3.45B |